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IMMUNOBIOLOGY
IL-21 receptor signaling is integral to the development of Th2 effector
responses in vivo
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1Institute of Integrative Biology, Molecular Biomedicine, Swiss Federal Institute of Technology (ETH) Zu¨rich, Switzerland; 2Deparment of Pathology, University of
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Interleukin 21 (IL-21) is a member of the
common -chain family of cytokines,
which influence a broad spectrum of im-
munologic responses. A number of stud-
ies have examined the function of IL-21,
but its specific role in Th1/Th2-cell differ-
entiation and related effector responses
remains to be clarified. Thus, we gener-
ated IL-21R–deficient mice and have in-
vestigated the role of IL-21R signaling
using a series of in vivo experimentally
induced disease models. We first ad-
dressed the role of IL-21R signaling in
Th2 immune responses by examining aller-
gic airway inflammation, and Nippostrongy-
lus brasiliensis and Heligmosomoides po-
lygyrus antihelminth responses. In each of
these systems, IL-21R signaling played a
clear role in the development of Th2 re-
sponses. Comparatively, IL-21R signaling
was not required for the containment of
Leishmania major infection or the develop-
ment of experimental autoimmune myocar-
ditis, indicative of competent Th1 and Th17
responses, respectively. Adoptive transfer
of T cells and analysis of IL-21R//IL-21R/
chimera mice revealed that IL-21R–signal-
ing was central to Th2-cell survival or migra-
tion to peripheral tissues. Overall, our data
show IL-21 plays a crucial role in supporting
polarized Th2 responses in vivo, while ap-
pearing superfluous for Th1 and Th17 re-
sponses. (Blood. 2007;109:2023-2031)
© 2007 by The American Society of Hematology
Introduction
Cytokines are key players in shaping immune responses against
both self and foreign antigens, influencing the induction of either
tolerance or effective immunity. While cytokines have a broad
spectrum of activities, distinct levels of redundancy due to the
sharing of common receptors, or receptor subunits, help ensure that
appropriate immune responses develop. Interleukin-2 (IL-2), IL-4,
IL-7, IL-9, and IL-15 belong to the type I cytokine family, and their
receptors share the common c chain and signal via the Jak/STAT
pathway.1-5 These cytokines play crucial roles in T-cell responses
including cell proliferation, differentiation, and maintaining memory
populations. IL-21 is the most recently described member of this
cytokine family,6,7 and a series of studies have shown that it has
pleiotropic effects upon the development of immune responses.
The main source of IL-21 is activated CD4 T cells, however
numerous other cell types express the receptor.6 It has been shown
to promote expansion of natural killer (NK) cells and augment their
antitumor activity8 but also to inhibit dendritic cell (DC) activation
and maturation in vitro.9 Furthermore, IgE isotype switching is
dysregulated in the absence of IL-21 receptor signaling, indicative
of a regulatory role for IL-21.10 The data to date concerning the role
of IL-21 in Th1 and Th2 responses are controversial.11 Addition of
IL-21 to in vitro T-cell cultures has been shown to have no
influence on the production of IL-4 and IL-5, while in vivo,
exogenous IL-21 can reduce the infiltration of eosinophils into the
airways (generally considered to be IL-5 dependent).12 A further
study has shown that IL-21 mRNA was exclusively detected in in
vitro and in vivo polarized Th2 cells, but not Th1 cells.13 This study
also showed that IL-21 inhibited IFN- production by Th1 cells in
vitro, although neither TNF- production nor T-bet expression was
compromised.13 In contrast, Strengell et al14 showed that IL-21 could
induce expression of genes involved in Th1 responses including IFN-,
the IL-12R chain, and T-bet. In an attempt to clarify the role of IL-21 in
both Th1 and Th2 immune responses, we have generated mice deficient
in the IL-21 receptor, and extensively assessed their ability to mount Th1
and Th2 responses in vivo. We found IL-21R expression was central to
the development of Th2-driven allergic airway inflammation as shown
by impaired Th2 cytokine production, infiltration of eosinophils, and
airway hyperresponsiveness. In support of prior publications, antibody
isotype switching was also dysregulated, characterized by reduced IgG1
and IgA and increased IgE production. In line with these data, Th2
responses against the parasites Nippostrongylus brasiliensis and Helig-
mosomoides polygyrus were similarly impaired. However, this immune
dysregulation was not a general phenomenon, as the development of
Th1 immune responses against Leishmania major and Th17-driven
experimental autoimmune myocarditis (EAM) were normal. Overall,
our data from in vivo disease models support a central role for IL-21
signaling in Th2, but not Th1 or Th17, immune responses.
Materials and methods
Mice and pathogens
C57BL/6 and BALB/c wild-type mice were obtained from Charles River
(Sulzfeld, Germany). IL-21R–deficient mice were generated as described in
“Generation of IL-21R–deficient mice” and backcrossed more then 5
generations onto the C57BL/6 background and 4 generations onto the
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BALB/c background. Mice were maintained in specific pathogen-free
conditions at the BioSupport (Zu¨rich, Switzerland) animal facility in
isolated ventilated cages. Animals used in experiments were between 8 and
10 weeks of age. N brasiliensis was maintained by passage through Lewis
rats; H polygyrus was passaged through IL-4/ mice on a C57BL/6
background. Mice were infected subcutaneously with 550 live N brasilien-
sis L3 worms or orally with 200 L3 H polygyrus worms and killed at day 14
after infection. For infection with L major, stationary-phase promastigotes
were collected from in vitro culture in biphasic Novy-Nicolle-McNeal
(NNN) blood agar medium, and 1 to 2  106 parasites were injected
subcutaneously into the right hind footpad. The infection was monitored
by measuring footpad swelling with a metric caliper (Kroepelin,
Schluchtern, Germany). Mice were killed and tissues taken at the
indicated time points. All animal experimental procedures were approved
by the Zu¨rich animal committee.
Genotyping of IL-21R–deficient mice
DNA was isolated from tails of mice by tissue lysis and DNA precipitation.
For the polymerase chain reaction (PCR), the following primers were used:
IL-21R–forward, 5-GCT AGC ACT TCT ATA GGC AAA GGG-3;
IL-21R–reverse, 5-CAG CTG AGC TTT GTG GGA GG-3; and NEO
3193, 5-CGA GAC TAG TGA GAC GTG CTA CTT CC-3. Using
Platinum Taq (Invitrogen, Frederick, MD), the reaction was performed in a
T 3000 Thermocycler (Biometra, Goettingen, Germany) over 35 cycles
with an annealing temperature of 58°C.
OVA-induced airway inflammation
Mice were immunized by intraperitoneal injection with 100 g OVA (grade
V; Sigma-Aldrich, Buchs, Switzerland) in 200 L alum adjuvant (SERVA;
Electrophoresis, Heidelberg, Germany). Ten days later, mice were chal-
lenged on the 4 following days by intranasal inoculation with 100 g OVA
in 50 L PBS.
Measurement of airway responsiveness
One day after last intranasal challenge with OVA, mice were placed in
individual unrestrained whole-body plethysmograph chambers (Buxco
Electronics, Petersfield, United Kingdom). Airway responsiveness was
assessed in mice by inducing airflow obstruction with aerosolized methacho-
line-chloride (MetCh). This procedure estimates total pulmonary airflow in
the upper and lower respiratory tracts. The chamber pressure was used as a
measure of the difference between thoracic expansion (or contraction) and
air volume removed from (or added to) the chamber during inspiration (or
expiration). Pulmonary airflow obstruction was assessed by measuring
PenH using BioSystem XA software (Buxco Electronics). Measurements of
MetCh responsiveness were obtained by exposing mice for 3 minutes to
incremental doses of aerosolized MetCh (Aldrich Chemie, Steinheim,
Germany) and monitoring the breathing pattern for 5 minutes after initiation
of aerosol dose.
Collection and analysis of BAL cells
Two days after the last intranasal challenge with OVA, mice were killed by
CO2 inhalation. The trachea was cannulated and bronchoalveolar lavage
(BAL) was performed by flushing the airways 3 times with 0.4 mL PBS.
Total BAL cells were counted using a Coulter Counter (IG Instruments,
Zu¨rich, Switzerland) and spun onto glass slides using a Cytospin 2
(Shandon Southern Products, Astmoor, England). Following fixation with
methanol for 2.5 minutes, cells were stained with undiluted May-Gru¨nwald
solution (Fluka, Buchs, Switzerland) for 3 minutes. A further staining was
performed in a 50% May-Gru¨nwald solution for 3 minutes. In a last step,
cells were stained in 7% Giemsa solution (Fluka) for 12 minutes. Slides
were rinsed with water and air-dried overnight. Dried cells were embedded
in Eukit solution under glass coverslips. Percentages of macrophages,
lymphocytes, neutrophils, and eosinophils were determined microscopi-
cally by counting 200 cells/sample using standard morphologic and
cytochemical criteria. Total numbers of eosinophils were derived by
multiplying the total number of leukocytes by the percentage of eosinophils
identified morphologically.
Generation of bone marrow chimeras
Recipient mice were lethally irradiated (9.5 Gy) by using a 60 Cobalt source
and were injected intravenously with 1  107 Thy 1–depleted bone marrow
(BM) cells that were collected from tibias and femurs of donor mice. After 6
weeks, reconstitution of the hematopoietic system was assessed by
fluorescence-activated cell sorting (FACS) analysis.
Adoptive transfer of SMARTA2 (Sm2) transgenic T cells
Naive CD4 T cells were isolated from spleens of Sm2 or IL-21R/ Sm2
mice and 1  107 T cells were adoptively transferred to C57BL/6. One day
after transfer, mice were immunized intraperitoneally with 50 g GP61-80
peptide in alum adjuvant. Ten days after immunization, mice were
challenged intranasally with 25 g GP61-80 on 2 consecutive days. Five days
after the first challenge, mice were killed and cells isolated for analysis.
TCR transgenic T-cell–DC coculture
Naive CD4 T cells were isolated from spleens by magnetic-activated cell
sorting (MACS) bead separation following the manufacturer’s instructions
(Miltenyi Biotech, Bergisch Gladbach, Germany) and were found to be
more than 90% CD4 CD62Lhigh by subsequent FACS analysis. DCs were
isolated from spleens of naive wild-type or IL-21R–deficient mice as
described previously.15 Isolated T cells (6.5  104 cells/well) and DCs
(1.4  104 cells/well) were cultured in 96-well plates in the presence of
GP61-80 peptide at a concentration of 10 nM. After 24 hours, T cells were
analyzed for expression of activation markers: cells were incubated with a
biotinylated anti-CD40L antibody in IMDM at 37°C. After 4 hours, cells
were washed twice with PBS/0.1% BSA and incubated with PE-labeled
anti-CD62L, APC-labeled anti-CD25, and PerCp-labeled Streptavidin (BD
Pharmingen, San Diego, CA) for 25 minutes at 4°C. Cells were washed
extensively and analyzed by flow cytometry. To assess proliferation,
purified SM2 transgenic T cells were labeled with 5 M CFSE (Molecular
Probes, Leiden, The Netherlands) by incubation at room temperature for
7 minutes. After extensive washing with IMDM, CFSE-labeled T cells were
cultured in the presence of GP61-80 and DCs. After 3 days, T cells were
harvested and stained with PerCp-labeled anti-CD4 antibody (BD
Pharmingen), and the CD4 T cells were analyzed for CFSE staining by
flow cytometry.
ELISA measurement of antibodies and cytokines
At the indicated time points, BAL fluid, serum, or culture supernatant was
analyzed for either total IgE, specific IgG1, specific IgA, IL-4, or IFN-.
Ninety-six–well plates (Maxisorp; Nunc, Roskilde, Denmark) were coated
with anti-IgE, anti–IFN-, or anti–IL-4 at 5 g/mL in 50 L PBS overnight
at 4°C. For antigen-specific enzyme-linked immunosorbent assays (ELISAs),
plates were coated with OVA at 50 mg/mL overnight at 4°C. Between all of
the following steps, plates were washed 5 times with PBS. Coated plates
were blocked with PBS/1% BSA for 2 hours at room temperature. Samples
from individual mice/cultures were serially diluted in PBS/0.1% BSA as
indicated, followed by incubation at room temperature for 2 hours.
Thereafter, alkaline phosphatase–labeled goat antimouse antibodies to IgE,
IgG1, IgA (Southern Biotechnology Associates, Birmingham, AL), IL-4, or
IFN- were added at room temperature for 2 hours, followed by addition of
the substrate p-nitrophenyl phosphate (Sigma-Aldrich). Optical density
(OD) was determined at 405 nm.
Proliferation assay
A single-cell suspension was made from the indicated lymph nodes by
gentle teasing through 70-m nylon cell strainers (Falcon; Becton Dickin-
son, Heidelberg, Germany) and cells were washed through the strainers
with IMDM into 50-mL (Falcon) tubes. Antigen at the indicated concentra-
tions was diluted in 96-well plates and 5  105 cells were added per well.
Cells were cultured for 72 hours at 37°C with [3H] thymidine added (1 Ci
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[0.037 MBq]/well) for the last 12 hours. Total [3H] thymidine incorporation
was measured as an indicator of cell proliferation.
Intracellular cytokine staining and FACS analysis
Approximately 5  105 cells from either BAL samples or in vitro culture
were stimulated with PMA (107 M) and ionomycin (1 g/mL). For the
final 2 hours, brefeldin A (10 g/mL) was added to the cultures. Thereafter,
cells were washed with PBS/0.1% BSA and incubated with anti-CD32/
CD16 mAb for 30 minutes at 4°C to block Fc binding. After another
washing step, cells were stained with PerCp-labeled anti-CD4 mAb (BD
PharMingen) for 15 minutes at 4°C. For basophil detection, blood samples
were stained with FITC-labeled IgE and with PE-labeled CD49b after
blocking. Subsequently, cells were washed with PBS/0.1% BSA, then again
in PBS, and fixed with 2% paraformaldehyde for 20 minutes at room
temperature. For intracellular staining, fixed cells were then incubated in
permeabilization buffer (0.5% saponin/PBS/1% BSA) containing APC-
labeled anti–IFN- and PE-labeled anti–IL-4 mAb (BD PharMingen) for 30
minutes at room temperature. Cells were washed twice in permeabilization
buffer and then resuspended in PBS/1% BSA and analyzed by flow
cytometry (FACSCalibur; Becton Dickinson) and Flowjo software (Tree
Star, Ashland, OR).
Induction of experimental autoimmune myocarditis and
histologic assessment
A murine heart muscle–specific peptide derived from -myosin H chain
(Ac-RSLKLMATLFSTYASADR-OH) was used as antigen. The peptide
(purity, 85%; ANAWA Biochemical Services and Products, Zu¨rich, Switzer-
land) was dissolved in CFA (Difco, Detroit, MI) and emulsified 1:1 with
PBS. Mice were immunized subcutaneously with 100 g/0.2 mL on days 0
and 7. Sham-immunized controls were injected with CFA emulsified with
PBS alone. Fourteen days after the second immunization, mice were killed,
and their hearts removed, fixed in 4% neutral buffered formalin, and
processed for hematoxylin and eosin staining. The glass slides were coded
and evaluated by a pathologist. For diagnosis of myocarditis, an inflamma-
tory infiltrate forming foci between muscle fibers or surrounding individual
myocytes, with or without associated myocyte necrosis or apoptosis, was
considered essential. A vague increase in interstitial cellularity was not
considered sufficient for diagnosis. Myocarditis was scored on a semiquan-
titative scale using grades from 0 to 4 (0 indicates no inflammatory
infiltrates; 1, small foci of inflammatory cells between myocytes or
inflammatory cells surrounding individual myocytes; 2, larger foci of 100
inflammatory cells or involving 30 myocytes; 3, 10% of a myocardial
cross-section involved; and 4, 30% of a myocardial cross-section involved).
Microscopy
Histology samples and blood smears were viewed using an Axioplan 2
microscope (Carl Zeiss, Jena, Germany) equipped with a Zeiss Plan-
Apochromat 63/1.4 numerical aperture (NA) oil or a Zeiss Plan-Neofluor
40/0.75 NA HF objective and a Retiga Exi CCD camera (Qimaging,
Burnaby, BC, Canada) with Openlab imaging software (Improvision,
Coventry, United Kingdom). Adobe Photoshop (Adobe Systems, San Jose,
CA) was used for image processing.
Statistics
Statistical significance was analyzed by the Student t test. Unless otherwise
indicated, data represent mean	 standard deviation, with P values less than
.05 statistically significant.
Results
Generation of IL-21R–deficient mice
IL-21R/ mice were generated by homologous recombination.
The targeting vector for IL-21R contained regions of exons 2 and 5
and was designed to replace the intervening IL-21R coding
sequence with a 3.3-kb neomycin resistance cassette (Figure 1A).
The target vector was electroporated into 129Sv ES cells, and
recombinant ES clones were identified by Southern blot analysis of
genomic DNA and microinjected into C57BL/6 blastocysts. Germ-
line transmission of the targeted allele was confirmed by Southern
blot of tail genomic DNA. The resulting chimera mice were
backcrossed onto either C57BL/6 or BALB/c strains. Mice were
genotyped by PCR as described in “Materials and methods”
(Figure 1B). The homozygous IL-21R–deficient mice were viable
and fertile and showed no gross developmental abnormalities. The
absence of IL-21R mRNA in cells derived from knock-out mice
was confirmed by reverse-transcription (RT)–PCR (Figure 1C).
Proportions of monocyte, lymphocyte, and granulocyte popula-
tions appeared normal in the IL-21R/ mice; however, circulating
IgE levels were increased approximately 2-fold in the IL-21R/
mice (data not shown).
IL-21R signaling is required for Th2 responses against
helminth parasites
Given the controversy over the role of IL-21 in Th2 immune
responses, we chose to investigate 2 well-defined in vivo models of
Th2 immunity, specifically, infection with the helminth parasites
Nippostrongylus brasiliensis (Nb) and Heligmosomoides polygyrus
(Hp). C57BL/6 and IL-21R/ mice on a C57BL/6 background
were infected subcutaneously with Nb and 14 days later the
infiltration of cells into the airways was assessed. The infiltration of
both eosinophils and lymphocytes was reduced in the absence of
IL-21R signaling (Figure 2A), supporting a role for IL-21 in the
development of Th2 cells and their effector function. In addition,
IgA and IgG1 levels in BAL fluid and serum were decreased in
IL-21R/ mice, while IgE was similar (Figure 2B and data not
shown). We next examined the immune response against the
intestinal helminth, Hp. C57BL/6 and IL-21R/ mice on a
C57BL/6 background were infected via oral gavage with Hp. On
day 14 after infection, the proportion of basophils both in the blood
and the spleen was significantly reduced in the absence of IL-21R
signaling (Figure 3A). Similarly, the proportion of eosinophils
Figure 1. Generation of IL-21R knock-out mice. (A)
The genomic structure of the IL-21 receptor gene, and
the targeting vector used for homologous recombination,
resulting in the disruption of exons 2 to 5 of the wild-type
gene. (B) Mice were genotyped by PCR with the wild-
type gene yielding a 503-bp product and the knock-out
gene yielding a 752-bp product. (C) IL-21R mRNA from
splenocytes of wild-type and IL-21R/ mice was as-
sessed by RT-PCR.
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circulating in the blood was also reduced in the IL-21R/ mice
compared with wild-type controls (Figure 3B). Intestinal granu-
loma formation was impaired both in size (Figure 3C) and number
(Figure 3D) in the IL-21R/ mice following Hp infection.
Splenocytes were isolated and restimulated for 3 days in the
presence of Hp excretory secretory (HES) antigens, followed by a
short restimulation with PMA and ionomycin. Surprisingly, intracel-
lular cytokine staining and FACS analysis revealed that there was
no significant difference in the proportion of IL-4– or IFN-–
producing CD4 T cells (Figure 3E), although total cell counts
were reduced overall (data not shown). These data indicated that
the Th2 cells, which had survived the 3-day culture, were still
capable of producing IL-4 and IFN-, even in the absence of
IL-21R signaling. In contrast, measurement of IL-4 and IFN- in
the supernatant of the cultures by ELISA showed significantly
reduced levels of IL-4 (Figure 3F) and increased levels of IFN-
(Figure 3G) in the absence of IL-21R signaling. Taken together,
these data indicate that while T cells can differentiate into Th2 cells
in the absence of IL-21R signaling, they have impaired expansion
or survival, and consequently in vivo and in vitro Th2 responses
are impaired.
IL-21R signaling is required for the development of Th2-driven
allergic airway inflammation
Systemic immunization followed by airway challenge with ovalbu-
min (OVA) is a standard method for inducing Th2-driven allergic
airway inflammation, airways hyperresponsiveness, and recruit-
ment of eosinophils. It has previously been reported that administra-
tion of exogenous IL-21 during immunization and challenge of
mice with OVA impairs the ensuing recruitment of eosinophils into
the airways.12 Suto et al12 showed that addition of IL-21 to T-helper
cell cultures did not influence Th1 or Th2 differentiation, while
other reports indicate that in vitro, IL-21 suppresses Th1 develop-
ment and has no effect on Th2 cells.13 In an attempt to clarify such
conflicting results, we immunized IL-21R/ and BALB/c control
mice with OVA followed by intranasal challenge with OVA as
described in “Materials and methods.” In contrast to the report
showing exogenous IL-21 can suppress eosinophil recruitment,12
the absence of IL-21R signaling in our system resulted in reduced
eosinophil recruitment compared with BALB/c controls (Figure
4A). Lymphocyte migration was similarly impaired, indicating that
IL-21 in fact supports lymphocyte expansion/migration and eosino-
phil maturation/migration to the airways. Expression of IL-21R on
eosinophils was not detectable by RT-PCR, indicating a direct
signal from IL-21 upon eosinophils was unlikely (data not shown).
Ex vivo restimulation of OVA-specific lymphocytes led to reduced
proliferation, suggesting expansion or survival of cells in vivo
might also be impaired in the absence of IL-21R signaling (Figure
4B). In line with these data, IL-21R/ mice were less responsive
to inhalation of increasing concentrations of MetCh, indicating that
this IL-13–dependent airway hyperresponsiveness was also influ-
enced by the absence of IL-21R signaling (Figure 4C). Notably,
reduced levels of IL-13 in the BAL fluid of IL-21R/ mice were
also detected (data not shown). OVA-specific IgG1 (Figure 4D) and
Figure 2. IL-21R signaling is required for Th2 responses against Nippostrongylus brasiliensis. C57BL/6 and IL-21R–deficient mice were infected subcutaneously with
Nb. On day 14 after infection, BAL was performed and (A) the total number of eosinophils, lymphocytes, and macrophages was determined by total and differential cell counts.
(B) Total IgA, IgG1, and IgE in the BAL fluid were assessed by ELISA. Data show averages 	 SD of a representative experiment using 5 to 6 mice per group. Similar results
were obtained in an independent experiment.
Figure 3. IL-21R signaling is required for Th2 responses against Heligmosomoides polygyrus. C57BL/6 and IL-21R–deficient mice were infected by oral gavage with
H polygyrus. On day 14 after infection, (A) the proportion of basophils in the blood and spleen were determined by FACS analysis. (B) The proportion of eosinophils circulating
in the blood was determined by differential cell counts of blood smears. Data show averages	 SD of a representative experiment using 5 to 6 mice per group. (C) H&E staining
of intestinal sections with granuloma indicated by arrows. (D) Granulomas were counted under a dissecting microscope. Splenocytes were cultured for 3 days in the presence
of HES, followed by a short restimulation with PMA and ionomycin. (E) The proportion of CD4 T cells producing IFN- and IL-4 was determined by intracellular cytokine
staining and FACS analysis. (F) IL-4 and (G) IFN- from supernatant of the sample cultures were measured by ELISA. Similar results were obtained in a repeat experiment.
(D-G) Circles indicate data of individual mice, and horizontal bars indicate averages of a group.
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IgA (Figure 4E) in the BAL fluid and serum (data not shown) were
reduced in the absence of the IL-21R; however, IgE production was
enhanced (Figure 4F) as previously reported.10 Overall, these data
indicate that IL-21 plays an important role in the development of
Th2-mediated allergic airway inflammation.
IL-21R/ Th2 cells exhibit reduced recruitment or
accumulation in the airways
To assess whether the defect in Th2 responses was due to impaired
T-cell priming by dendritic cells, we used an in vitro system where
either C57BL/6 or IL-21R/ DCs were cultured together with
TCR transgenic Sm2 CD4 T cells in the presence of GP61-80
peptide. After 24 hours, we analyzed the T cells for expression of
activation markers (Figure 5A) and proliferation (Figure 5B). No
differences between cells primed by C57BL/6 or IL-21R/ DCs
were found, indicating IL-21R–signaling in DCs was not required
for T-cell activation. We then analyzed the ability of CD4 T cells
lacking the IL-21R to migrate to draining lymph nodes and
inflamed peripheral tissue in vivo. IL-21/ or IL-21/ TCR
transgenic Sm2 CD4 cells, which can be tracked in vivo by
expression of V2, were adoptively transferred into C57BL/6
mice. Recipient mice were immunized with GP61-80 peptide in alum
adjuvant and after 10 days challenged with GP61-80 peptide
intranasally. We analyzed draining LNs and the BAL for presence
of transgenic CD4 T cells. While there was no difference in the
percentage of V2CD4 cells in the draining LN of either group
(Figure 5C), we found less Va2CD4 cells in the BALs of mice
receiving IL-21R/ Sm2 T cells (Figure 5D). Total numbers of
CD4 T cells in BALs were comparable in both groups, likely
representing the nonspecific migration of endogenous memory
CD4 T cells to the site of inflammation. In addition, eosinophil
numbers in the airways of mice receiving IL-21R/ Sm2 cells
were reduced, supporting our previous findings with Nb infection
and OVA-induced allergic airway inflammation (Figure 5E). Thus,
while homing or survival of IL-21R/ Sm2 cells to the draining
LN appears to be normal, the recruitment or survival of IL-21R/
Figure 4. IL-21R signaling is required for the develop-
ment of Th2-driven allergic airway inflammation. BALB/c
and IL-21R–deficient mice were immunized intraperitoneally
with OVA protein adsorbed in alum adjuvant, followed 10
days later by intranasal challenge with OVAon 4 consecutive
days. Two days after the final intranasal challenge (A) The
number of eosinophils, lymphocytes, and macrophages that
had infiltrated into the airways was determined by BAL and
differential cell counts; (B) lung draining lymph nodes were
removed and total lymph node cells cultured in the presence
of OVAprotein for 72 hours. [3H] thymidine incorporation over
the last 12 hours of culture was measured as an indicator of
cell proliferation. (C) One day after intranasal challenge, mice
were exposed to increasing concentrations of acetyl--
methacholine-chloride (MetCh) and airway hyperresponsive-
ness was determined using a full-body unrestrained plethys-
mograph. (D) OVA-specific IgG1, (E) IgA, and (F) total IgE
were measured in BAL fluid. Data show averages	 SD of a
representative experiment using 4 to 7 mice per group.
Similar results were obtained in 3 independent experiments.
Figure 5. Normal T-cell priming but reduced T-cell recruitment to the airways in the absence of IL-21R signaling. DCs isolated from either C57BL/6 or IL-21R–deficient
mice were cocultured with CFSE-labeled Sm2 T cells in the presence of GP61-80 peptide. (A) After 24 hours, cells were collected and stained for the activation markers CD62L,
CD25, and CD40L. (B) Proliferation was assessed by FACS analysis of CFSE-stained cells. IL-21/ or IL-21/ TCR transgenic Sm2 CD4 cells were adoptively transferred
into C57BL/6 mice. Mice were immunized with GP61-80 peptide in alum adjuvant. After 10 days, mice were challenged intranasally on 4 consecutive days. One day after the final
challenge, the (C) DLNs and (D) BALs were analyzed for the percentage of the transferred Sm2 cells (Va2CD4) by FACS. (E) The number of eosinophils in the BAL was
determined by differential cell counts. Numbers in histograms represent geometric mean; numbers above gates represent percentage of cells in gate. (C-E) Column plots
indicate averages	 SD of a representative experiment using 4 to 5 mice per group. Similar results were observed in 3 independent experiments.
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CD4 T cells to the site of inflammation is impaired. As a
consequence of the reduced number of Th2 cells in the airways,
there is a reduced influx of eosinophils.
While it was likely that CD4 T cells were primarily accountable
for the reduced Th2 responses, we also sought to clarify the
contribution of nonhematopoietic cells. Accordingly, we lethally
irradiated C57BL/6 mice or IL-21R/ mice and reconstituted the
hematopoietic compartment with bone marrow derived from either
C57BL/6 or IL-21R/ mice. After successful reconstitution, we
induced the model of allergic airway inflammation as described in
“Materials and methods.” Analysis of draining LNs showed no
significant differences in the CD4 T-cell compartment (Figure 6A).
In the BAL, however, a clear reduction of CD4 T cells in both
groups that received IL-21R/–derived BM compared with the
groups that received C57BL/6 BM was evident. In line with this,
the number of eosinophils was strongly reduced in IL-21R/ BM
recipients (Figure 6B). IL-4 production by BAL-derived CD4 T
cells was reduced in IL-21R/ BM recipients, while IFN-
production was comparable or elevated (Figure 6C). These findings
support the conclusion that the absence of IL-21R on CD4 T cells is
the primary factor that leads to the overall reduced Th2 response.
Notably, the impairment of CD4 T cell recruitment to the airways
was slightly greater when IL-21R/ was absent in both the
hematopoietic and nonhematopoietic compartments, indicating a
secondary role for cells of the nonhematopoietic systems in the
recruitment or accumulation of CD4 T cells to the airways.
IL-21R signaling is not required to mount a resistant Th1
response against Leishmania major
Th2 immune responses appear to be particularly sensitive to the
absence of the IL-21R on T cells. In order to clarify the role of
IL-21R signaling in Th1 immunity, we assessed the ability of
IL-21R/ mice on a C57BL/6 background to respond to L
major infection. Wild-type C57BL/6 mice respond to L major
infection with a Th1 response dominated by the induction of
IFN- that enables macrophages to kill the parasite and clear the
infection.16-18 IL-21R/ and wild-type C57BL/6 mice were
infected with 2  106 parasites in the right hind footpad. The
inflammatory response was monitored weekly by measuring the
swelling of the infected, compared with uninfected, footpad. No
difference in footpad swelling was evident between IL-21R/
and wild-type control mice (Figure 7A). Restimulation of
lymphocytes isolated from the draining lymph node with L
major soluble antigens showed a significantly increased propor-
tion of IFN-–producing CD4 T cells from the IL-21R/ mice
(Figure 7B), which became more pronounced at later time points
(data not shown). These data indicate that IL-21R expression is
not required for the development of Th1 immunity but, in fact,
may suppress it.
The development of Th17-driven experimental autoimmune
myocarditis is independent of IL-21R signaling
The role of Th1 and Th2 cytokines in the development of
experimental autoimmune myocarditis (EAM) has been controver-
sial. Recently, however, we found that EAM is in fact mediated by
the Th17 cell subset.19 We sought to establish whether IL-21R
signaling was involved in the development of Th17-mediated
EAM. Mice were immunized with myosin peptide in CFA on days
0 and 7, and on day 21 were killed and hearts taken for histologic
analysis. A comparable severity and prevalence of disease devel-
oped in both IL-21R/ and IL-21R/ littermate controls (Figure
7C). Histologic examination revealed the infiltrate in IL-21R/
mice and IL-21/ littermate controls consisted primarily of
macrophages and lymphocytes, with some granulocytes also being
present (Figure 7D). No significant difference was detected in
either the number or nature of the cell infiltrate. Overall, these data
show that IL-21R signaling is superfluous for the development of
Th17-mediated EAM.
Figure 6. The absence of IL-21R on hematopoietic cells is primarily
responsible for impaired Th2 immune responses in the lung. Recon-
stituted bone marrow chimeras were immunized intraperitoneally with
OVA adsorbed in alum adjuvant, followed 10 days later by intranasal
challenge with OVA on 4 consecutive days. Two days after the final
challenge, the number of CD4 T cells in (A) DLN and (B) BAL was
determined by FACS analysis. (C) Eosinophils that had infiltrated into the
airways were determined by differential counts. (D) The proportion of
CD4 T cells producing IL-4 and IFN- was determined after PMA/
ionomycin restimulation by intracellular cytokine staining and FACS
analysis. Column plots indicate averages 	 SD of a representative
experiment using 4 mice per group.
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Discussion
Extensive research has shown that cytokines belonging to the type
1 cytokine family have a broad spectrum of activities, some of
which might be considered conflicting. IL-4 for example is
classically associated with the polarization and effector function of
Th2 cells,20 and IL-4/ mice are defective in Th2 responses.21
However, it has also been reported that IL-4 promotes development
of CD8 cytotoxic T cells in tumor22 and viral23 models (typically
associated with Th1, not Th2, responses). Similarly, IL-2 drives
both Th1- and Th2-cell proliferation, while being important for
stabilizing the accessibility of the Il4 gene and consequently Th2,
not Th1, differentiation.24 IL-21 appears to follow suit in this
respect, exhibiting pleiotropic effects in innate and adaptive
immunity. A body of literature now supports a role for IL-21 in NK
T-cell development and effector function,25-29 and B-cell antibody
isotype switching.10,12,30-33 Furthermore, addition of IL-21 has been
shown to drive IFN- production in synergy with IL-15.28,34
However defining a role for IL-21 in Th1 and Th2 development
remains controversial, possibly due to the nature of the in vitro
systems used and the administration of exogenous cytokines.
In this paper, we have generated IL-21 receptor–deficient mice to
allow the role of IL-21 during in vivo Th1, Th2, and Th17 disease models
to be addressed. We first addressed Th2 immune responses, which are
known to drive allergic airway inflammation and immunity against
helminth parasites. In a model of OVA-induced allergic airway inflamma-
tion, IL-21R–deficient mice exhibited a reduced hyperresponsiveness
upon inhalation of methacholine. In this model, AHR is typically
associated with the activity of the Th2 cytokine IL-13, indicating that the
IL-13 response was impaired in the absence of IL-21R signaling. In
support of this result, analysis of the BAL fluid revealed reduced levels of
IL-13 (data not shown). It has been shown that recruitment of eosinophils
to the lung is dependent on the in vivo activity of IL-5,35,36 but the question
remained whether the reduced eosinophil recruitment was due to an
inherent defect relating to the absence of the IL-21R, or whether it was a
consequence of reduced lymphocyte migration into the airways and thus
reduced release of IL-5. IL-21R expression was not detectible on
eosinophils (data not shown), arguing against an inherent defect in these
cells. Rather, the adoptive transfer experiments indicated that migration of
IL-21R–deficient Sm2 T cells into the lung was impaired, while their
survival and accumulation in the draining LN were comparable with
wild-type T cells. These data were supported by the BM chimeras, which
similarly showed reduced CD4 T-cell numbers in the BAL of IL-21R–
deficient BM recipients. Notably, the cytokine profiles of IL-21R/
CD4 T cells that had reached the lung showed reduced IL-4, and
enhanced IFN-, production. The consequence of lower numbers of Th2
cells, and their reduced IL-4 production, is the likely mechanism
underlying the reducedeosinophil recruitmentandairwayhyperresponsive-
ness. It remains to be definitively shown whether the reduced CD4T-cell
numbers in the lung are due to a reduced survival and accumulation or to
an impairment in cell migration; however, given the nature of the common
gamma chain family of cytokine receptors, impaired survival is the most
plausible explanation.
In the absence of IL-21R signaling, T helper cell–dependent
antigen-specific IgA and IgG1 in the BAL were decreased in line
with the reduced number of eosinophils and lymphocytes. While
the impaired antibody response is likely to be secondary to the
decreased CD4 T-cell response, it remains possible that the
absence of the IL-21R on B cells may play a direct role.
Suto et al12 have shown that addition of IL-21 leads to reduced
IgE and eosinophil migration in a model of OVA-induced allergic
airway inflammation. While our data showing increased IgE
production in the IL-21R/ mice support their data, it is difficult to
reconcile why eosinophil numbers and IgG1 production are
reduced in both the absence of IL-21R and upon addition of IL-21.
Further studies are required to clarify this issue, but possibilities
include the following: IL-21 may play distinct roles at different
stages of immune responses (potentially acting in synergy with
different cytokines); its reported effect may be mediated through
another cell type (eg, NK cells); or it might additionally signal
through an as-yet-unidentified receptor.
An important question is whether IL-21, like its closest relative
IL-2, is primarily involved in driving proliferation or polarization
of T cells. The most well-accepted role for IL-2 is to enhance T-cell
proliferation; however, it plays a clear role in Th2 differentiation.
Our ex vivo proliferation experiments with OVA-specific T cells
indicate that IL-21R signaling is critical for T-cell proliferation.
Indeed, addition of IL-21 to in vitro cultures has been proved to
enhance proliferation (Parrish-Novak et al6; Kasaian et al37; and
data not shown), as does its closest related cytokine, IL-2. However
IL-21 did not play a major role in mediating Th2-cell differentia-
tion in vitro.13 The primary role of IL-21 in T-cell differentiation
appears to support IL-4–mediated Th2 polarization, rather than to
drive polarization itself. In line with this hypothesis, it has been
shown that T cells isolated from IL-21R–deficient mice have no
defect in polarization.10 However, exposure of naive T cells to
IL-21 followed by culture in Th1-polarizing conditions resulted in
a down-regulation of IFN- expression, while IL-21 did not affect
already polarized Th1 cells.13 We have also seen a reduction in
IFN- production upon addition of IL-21, which becomes more
pronounced in the presence of IL-4 (A.F., B.J.M., M.K.,
Figure 7. IL-21R–deficient mice exhibit a Th1 R/ response following infection with Leishmania major and Th 17-mediated protection from autoimmune
myocarditis. (A,B) C57BL/6 and IL-21 (N5, C57BL/6) were infected with 2  106 promastigotes of L major in the hind footpad. (A) At the time points indicated, the course of
disease was monitored using metric calipers to determine footpad swelling. (B) Three weeks after infection, the draining lymph node was removed and isolated cells were
restimulated with PMA and ionomycin for 4 hours. IFN- production by CD4 T cells was assessed by FACS. Values show percentage of IFN-–producing cells, gated on CD4
cells. Data are from a representative experiment using 3 to 5 mice per group. (C,D) IL-21R/ (N4, BALB/c) and littermate control IL-21R/ mice were immunized with
-myosin-peptide in CFA on days 0 and 7, and were killed 14 days later. Hearts were removed and fixed in 4% buffered formalin, and histological sections were evaluated. (C)
The severity of inflammatory infiltrates were assessed and scored as described in “Materials and methods.” Horizontal lines represent the median value for each group. (D)
Representative images of H&E-stained heart tissue. Original magnification, 15 (left column), 60 (middle column), and 400 (right column).
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unpublished data, March 2006). It is plausible that this phenom-
enon is linked to the well-established Th1/Th2 counterregulatory
paradigm, with IL-21 playing a similar and supportive role to IL-4
in the suppression of Th1 development. However, considering
IL-21 signals predominantly through STAT338 and IL-4 signals
through STAT6,39 is it likely that the pathways underlying this
may be distinct.
Given that a “resistant” phenotype against L major is generally
associated with effective Th1 immune responses, the comparable footpad
swelling between C57BL/6 and IL-21R/ mice after infection with L
major suggests IL-21R signaling is not required for effective Th1-
mediated responses. Surprisingly, a significantly higher proportion of
lymphocytes isolated from IL-21R/ mice, previously infected with L
major, produced IFN-, further supporting the hypothesis that IL-21 can
impair Th1 polarization. Induction of experimental autoimmune myocar-
ditis was also comparable between wild-type and IL-21R–deficient mice.
These data suggest that any contribution of Th2 cytokines to the
development of this disease must be minimal, or unnecessary, for normal
disease development, and further indicate that IL-21 is not required for
immune responses driven by IL-17.19
Clearly IL-21 exerts pleiotropic effects upon the development
of innate and adaptive immune responses, and thus is a potential
target for therapy. Our results would indicate that neutralizing
IL-21 might be beneficial for the treatment of allergic asthma.
However, while this could potentially be effective at reducing
airway hyperresponsiveness and infiltration of lymphocytes, the
resulting high circulating levels of IgE could have direct conse-
quences. In addition, inhibiting the reported role for IL-21 in
NK-cell effector function is unlikely to be therapeutically benefi-
cial. Administering IL-21, however, might be a more promising
alternative. Here, IgE production could be reduced, and potentially
NK-cell function could be enhanced, although such treatment has
been shown to exacerbate EAE.40 The implications these data have
on potential therapeutics remain to be seen.
Overall, our data suggest the importance of IL-21R signaling in vivo
may be on 3 distinct levels: (1) the suppression of IFN- production; (2)
the direct regulation of B-cell IgE isotype switching; and (3) enhancing
T-cell survival. The pronounced sensitivity of Th2 responses to the
absence of IL-21 signaling in vivo indicates that this cytokine is key to
Th2, rather than Th1 or Th17, inflammation.
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